In part 2 Prof. Nicolas Mottet discusses which are the most important changes in the new EAU Guidelines for Prostate Cancer treatment related to genetic testing, M1 disease and Castration-resistant prostate cancer (CRPC). 

Listen also to part 1 about perineal biopsy, staging PSMA, adjuvant Radio Therapy.